These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1420823)
41. Prothrombin fragment 1 + 2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients. Gruden G; Cavallo-Perin P; Romagnoli R; Olivetti C; Frezet D; Pagano G Diabet Med; 1994 Jun; 11(5):485-8. PubMed ID: 8088128 [TBL] [Abstract][Full Text] [Related]
42. Modified antithrombin III levels during normal pregnancy and relationship with prothrombin fragment F1 + 2 and thrombin-antithrombin complexes. Reber G; Amiral J; de Moerloose P Thromb Res; 1998 Jul; 91(1):45-7. PubMed ID: 9700853 [No Abstract] [Full Text] [Related]
43. Activation of the endogenous coagulation system in patients with atrial flutter: relationship to echocardiographic markers of thromboembolic risk. Kamath GS; Herweg B; Cotiga D; Pierce W; Cohen AJ; Chaudhry FA; Drejka ML; Steinberg JS Cardiol J; 2010; 17(4):390-6. PubMed ID: 20690096 [TBL] [Abstract][Full Text] [Related]
44. Changes in plasma levels of prothrombin fragment F 1 + 2 in cases of disseminated intravascular coagulation. Asakura H; Shiratori Y; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T Acta Haematol; 1993; 89(1):22-5. PubMed ID: 8480481 [TBL] [Abstract][Full Text] [Related]
45. Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. BAATAF Investigators. Kistler JP; Singer DE; Millenson MM; Bauer KA; Gress DR; Barzegar S; Hughes RA; Sheehan MA; Maraventano SW; Oertel LB Stroke; 1993 Sep; 24(9):1360-5. PubMed ID: 8362431 [TBL] [Abstract][Full Text] [Related]
47. Are prothrombin fragment 1 + 2 and thrombin-antithrombin complexes useful in the management of oral anticoagulant therapy? Barcellona D; Biondi G; Mameli G; Marongiu F Int J Clin Lab Res; 1997; 27(1):76-8. PubMed ID: 9144033 [TBL] [Abstract][Full Text] [Related]
48. Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation. Kamath S; Blann AD; Caine GJ; Gurney D; Chin BS; Lip GY Stroke; 2002 May; 33(5):1237-42. PubMed ID: 11988597 [TBL] [Abstract][Full Text] [Related]
49. [Evaluation of oral anticoagulation with rivaroxaban, in patients with new onset non valvular atrial fibrillation]. Neira V; Corbalán R; Pereira J; Panes O; Garayar B; Aizman A; Llevaneras S; Villarroel L Rev Med Chil; 2016 Sep; 144(9):1103-1111. PubMed ID: 28060970 [TBL] [Abstract][Full Text] [Related]
50. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease. Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668 [TBL] [Abstract][Full Text] [Related]
51. Thrombosis from a prothrombin mutation conveying antithrombin resistance. Miyawaki Y; Suzuki A; Fujita J; Maki A; Okuyama E; Murata M; Takagi A; Murate T; Kunishima S; Sakai M; Okamoto K; Matsushita T; Naoe T; Saito H; Kojima T N Engl J Med; 2012 Jun; 366(25):2390-6. PubMed ID: 22716977 [TBL] [Abstract][Full Text] [Related]
52. Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Feinberg WM; Pearce LA; Hart RG; Cushman M; Cornell ES; Lip GY; Bovill EG Stroke; 1999 Dec; 30(12):2547-53. PubMed ID: 10582976 [TBL] [Abstract][Full Text] [Related]
53. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Lip GY; Lip PL; Zarifis J; Watson RD; Bareford D; Lowe GD; Beevers DG Circulation; 1996 Aug; 94(3):425-31. PubMed ID: 8759084 [TBL] [Abstract][Full Text] [Related]
54. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements. Leroy-Matheron C; Gouault-Heilmann M Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241 [TBL] [Abstract][Full Text] [Related]
55. L-asparaginase induced antithrombin III deficiency: evidence against the production of a hypercoagulable state. Bauer KA; Teitel JM; Rosenberg RD Thromb Res; 1983 Feb; 29(4):437-42. PubMed ID: 6857592 [TBL] [Abstract][Full Text] [Related]
56. Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation? Zeuthen EL; Lassen JF; Husted SE Thromb Res; 2003 Mar; 109(5-6):241-6. PubMed ID: 12818245 [TBL] [Abstract][Full Text] [Related]
57. Rate-related hypercoagulable state in mitral stenosis with atrial fibrillation: Can strict rate control prevent thrombus formation? Panduranga P; Chase D; George O Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S7-9. PubMed ID: 26688156 [No Abstract] [Full Text] [Related]
58. Plasma levels of coagulation and fibrinolysis markers in acute ischemic stroke patients with lone atrial fibrillation. Topcuoglu MA; Haydari D; Ozturk S; Ozcebe OI; Saribas O Neurol Sci; 2000 Aug; 21(4):235-40. PubMed ID: 11214663 [TBL] [Abstract][Full Text] [Related]
59. Short-time stability of markers of coagulation and fibrinolysis in frozen plasma. Iversen LH; Thorlacius-Ussing O Thromb Res; 1996 Jan; 81(2):253-61. PubMed ID: 8822140 [TBL] [Abstract][Full Text] [Related]